The PRISM Emerging Gene Therapy Index tracks small/micro-cap stocks which are developing or marketing treatments that are gene-based or otherwise target genetic material. Please note the default display sorts the companies by percent daily change. Additional sorting options allow sorting by name, volume, and percent change since index inception date.
| PRISM Emerging Gene Therapy IndexInception Date of 1/2/2020 at $100.00 | % Change (Daily) | Current Index Value | % Change (Inception) | |||||
|---|---|---|---|---|---|---|---|---|
| 0.6% | $55.20 | -44.8% | ||||||
| Index Components | Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volume (1,000s) | Market Cap (Millions) | 1/2/2020 Price | % Change Since Inception 1/2/2020 |
| Abeona Therapeutics Inc. | ABEO | $3.14 | -2.181% | 98 | 143 | $59 | $3.21 | -2.2% |
| Adverum Biotechnologies, Inc. | ADVM | $0.99 | 3.375% | 232 | 401 | $100 | $11.74 | -91.5% |
| Allogene Therapeutics, Inc. | ALLO | $5.53 | 1.097% | 1,259 | 2,065 | $807 | $26.22 | -78.9% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | $33.60 | 0.089% | 794 | 1,167 | $3,592 | $63.12 | -46.8% |
| Atara Biotherapeutics, Inc. | ATRA | $1.77 | -7.813% | 1,876 | 1,504 | $173 | $16.41 | -89.2% |
| AVROBIO, Inc. | AVRO | $1.18 | 2.609% | 514 | 2,125 | $52 | $20.61 | -94.3% |
| BridgeBio Pharma, Inc. | BBIO | $13.75 | 1.551% | 1,409 | 3,201 | $2,207 | $33.22 | -58.6% |
| Bellicum Pharmaceuticals, Inc. | BLCM | $0.78 | 2.092% | 94 | 2,986 | $7 | $15.10 | -94.9% |
| bluebird bio, Inc. | BLUE | $3.56 | 2.299% | 2,570 | 4,785 | $379 | $86.37 | -95.9% |
| Benitec Biopharma Inc. | BNTC | $0.23 | -4.022% | 322 | 305 | $6 | $6.98 | -96.8% |
| Cellectis S.A. | CLLS | $1.84 | 3.371% | 21 | 70 | $105 | $17.81 | -89.7% |
| CRISPR Therapeutics AG | CRSP | $64.66 | 1.269% | 1,016 | 1,282 | $5,104 | $59.32 | 9.0% |
| Celyad Oncology SA | CYAD | $0.47 | -12.963% | 49 | 19 | $14 | $11.25 | -95.8% |
| Precision BioSciences, Inc. | DTIL | $0.74 | 0.915% | 557 | 562 | $84 | $13.14 | -94.4% |
| Editas Medicine, Inc. | EDIT | $9.10 | 0.22% | 1,062 | 1,828 | $628 | $29.44 | -69.1% |
| Fate Therapeutics, Inc. | FATE | $5.13 | 1.786% | 1,669 | 2,650 | $505 | $19.47 | -73.7% |
| Fortress Biotech, Inc. | FBIO | $0.55 | 11.835% | 1,260 | 593 | $74 | $2.71 | -79.7% |
| Homology Medicines, Inc. | FIXX | $1.02 | 0.99% | 115 | 152 | $59 | $20.53 | -95.0% |
| Mustang Bio, Inc. | MBIO | $5.19 | 3.387% | 78 | 55 | $42 | $4.10 | 26.6% |
| MeiraGTx Holdings plc | MGTX | $6.58 | 4.365% | 128 | 144 | $391 | $19.72 | -66.7% |
| NeuBase Therapeutics, Inc. | NBSE | $0.18 | 2.286% | 337 | 461 | $6 | $6.90 | -97.4% |
| Intellia Therapeutics, Inc. | NTLA | $38.98 | -0.612% | 769 | 1,098 | $3,436 | $14.58 | 167.4% |
| OncoSec Medical Incorporated | ONCS | $0.45 | -0.489% | 35 | 2,753 | $3 | $1.88 | -76.2% |
| Orgenesis Inc. | ORGS | $1.22 | 3.39% | 19 | 47 | $35 | $4.50 | -72.9% |
| Orchard Therapeutics plc | ORTX | $5.14 | 3.317% | 21 | 70 | $95 | $13.58 | -62.2% |
| Precigen, Inc. | PGEN | $1.22 | 1.667% | 997 | 1,449 | $312 | $5.91 | -79.4% |
| uniQure N.V. | QURE | $19.45 | -0.867% | 310 | 532 | $926 | $70.26 | -72.3% |
| Rocket Pharmaceuticals, Inc. | RCKT | $21.20 | 1.581% | 453 | 826 | $1,706 | $23.31 | -9.1% |
| REGENXBIO Inc. | RGNX | $18.20 | -0.329% | 349 | 450 | $791 | $38.99 | -53.3% |
| Sangamo Therapeutics, Inc. | SGMO | $1.26 | -5.263% | 3,386 | 2,367 | $217 | $8.21 | -84.7% |
| Solid Biosciences Inc. | SLDB | $6.16 | 2.667% | 8 | 35 | $121 | $4.43 | 39.1% |
| Stoke Therapeutics, Inc. | STOK | $10.92 | 2.922% | 75 | 232 | $483 | $26.54 | -58.9% |
| Syros Pharmaceuticals, Inc. | SYRS | $3.70 | -1.333% | 94 | 109 | $76 | $7.13 | -48.1% |
| Telesis Bio, Inc. | TBIO | $37.36 | 0% | 1,275 | 2,913 | $1,106 | $7.90 | 372.9% |
| Voyager Therapeutics, Inc. | VYGR | $12.05 | 0.921% | 519 | 469 | $525 | $13.58 | -11.3% |
| Wave Life Sciences Ltd. | WVE | $3.66 | -2.66% | 362 | 361 | $360 | $7.98 | -54.1% |
| ZIOPHARM Oncology, Inc. | ZIOP | $0.87 | -0.882% | 2,128 | 2,363 | $208 | $4.62 | -81.3% |
